Nagasawa Hayato

ナガサワハヤト | Nagasawa Hayato

MISC (35)：

Masayoshi Harigai, Akito Takamura, Tatsuya Atsumi, Makoto Dohi, Shintaro Hirata, Hideto Kameda, Hayato Nagasawa, Yohei Seto, Takao Koike, Nobuyuki Miyasaka. Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: A report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs. Modern Rheumatology. 2013. 23. 2. 284-296
Takamura A, Hirata S, Nagasawa H, Kameda H, Seto Y, Atsumi T, Dohi M, Koike T, Miyasaka N, Harigai M. Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.A retrospective study of serum・・・. Mod Rheumatol. 2013. 23. 2. 297-303
Eiko Nishi, Hideto Kameda, Hiroe Ogawa, Hayato Nagasawa, Hirofumi Takei, Ayumi Okuyama, Takahiko Kurasawa, Tsuneo Kondo, Koji Nishimura, Yuichiro Shirai, et al. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis. MODERN RHEUMATOLOGY. 2013. 23. 1. 97-103
Ryoko Sakai, Michi Tanaka, Toshihiro Nanki, Kaori Watanabe, Hayato Yamazaki, Ryuji Koike, Hayato Nagasawa, Koichi Amano, Kazuyoshi Saito, Yoshiya Tanaka, et al. Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules. ANNALS OF THE RHEUMATIC DISEASES. 2012. 71. 11. 1820-1826
Michi Tanaka, Ryoko Sakai, Ryuji Koike, Yukiko Komano, Toshihiro Nanki, Fumikazu Sakai, Haruhito Sugiyama, Hidekazu Matsushima, Toshihisa Kojima, Shuji Ohta, et al. Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors. Modern rheumatology. 2012. 22. 6. 849-858

ｍore...

Books (3)：

エタネルセプトの基本情報と使い方抗リウマチ薬Q&A
日本医学出版(東京) 2005
エタネルセプトの副作用の特徴抗リウマチ薬Q&A
日本医学出版(東京) 2005
エタネルセプトの臨床効果の特徴抗リウマチ薬Q&A
日本医学出版(東京) 2005

Lectures and oral presentations (5)：

The efficacy of tocilizumab for adult-onset Still's disease
(The 15th Congress of Asisa Pacific League of Associations for Rheumatology 2012)
THE ADDITION OF ANOTHER DISEASE-MODIFYING ANTI-RHEUMATIC DRUG TO METHOTREXATE IN PLACE OF INFLIXIMAB IMPROVES THE RATE OF INFLIXIMAB-FREE SUSTAINED REMISSION:RESULTS FROM THE BuSHIDO TRIAL
(EULAR 2012)
心アミロイドーシスを合併した強皮症の一例
(第49回関東リウマチ研究会 2008)
Infliximab投与によるHAQの改善および関節破壊阻止
(第105回日本内科学会講演会 2008)
Infliximab投与によるHAQの改善および関節破壊阻止
(第52回日本リウマチ学会総会・学術集会 2008)

Work history (4)：

2007 - 2009 埼玉医科大学医学部総合医療センターリウマチ・膠原病内科助教
2009 - - 埼玉医科大学医学部総合医療センターリウマチ・膠原病内科専任講師
2004 - 2007 埼玉医科大学医学部総合医療センターリウマチ・膠原病内科助手
Saitama Medical University Faculty of Medicine Lecturer

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page